Skip to main content
. 2020 Feb 19;4(3):524–534. doi: 10.1002/bjs5.50265

Table 1.

Clinical characteristics of the patients

Infection (n = 100) Sepsis (n = 95) Septic shock (n = 57) P (infection versus sepsis) P (infection versus septic shock) P (sepsis versus septic shock)
Age (years) * 57·0 (39·25–70·50) 73·0 (59–80) 74·0 (68–78·5) < 0·001 < 0·001 1·000
Male sex 60 (60·0) 62 (65) 31 (54) 0·448 0·493 0·183
Co‐morbidity
Chronic cardiovascular disease 13 (13·0) 28 (29) 21 (37) 0·005 < 0·001 0·347
Chronic respiratory disease 2 (2) 13 (14) 6 (11) 0·003 0·022 0·569
High BP 30 (30·0) 47 (49) 34 (60) 0·009 < 0·001 0·223
Chronic renal failure 2 (2·0) 9 (9) 7 (12) 0·024 0·004 0·388
Chronic hepatic failure 4 (4·0) 2 (2) 1 (2) 0·422 0·423 0·880
Diabetes mellitus 14 (14·0) 20 (21) 17 (30) 0·194 0·017 0·222
Cancer 13 (13·0) 18 (19) 13 (23) 0·256 0·112 0·568
Immunosuppression 5 (5·0) 13 (14) 6 (11) 0·037 0·205 0·553
Surgery type
Urgent 70 (70·0) 74 (78) 41 (72) 0·210 0·798 0·407
Abdominal 65 (65·0) 54 (57) 24 (42) 0·243 0·005 0·078
Cardiothoracic 0 (0) 14 (15) 14 (25) < 0·001 < 0·001 0·130
Vascular 1 (1·0) 3 (3) 1 (2) 0·288 0·685 0·601
Urological/renal 0 (0) 0 (0) 1 (2) § 0·184 0·195
Other 13 (13·0) 4 (4) 4 (7) 0·030 0·246 0·453
Time course and outcome
Length of hospital stay (days)* 5 (2–12) 15 (8–29·5) 31 (18·50–48·75) < 0·001 < 0·001 < 0·001
Length of ICU stay (days)* 0·5 (0–2) 3 (1–6·75) 7 (3–13) < 0·001 < 0·001 0·001
Hospital mortality 0 (0) 7 (7) 22 (39) 0·006 < 0·001 < 0·001
Source of infection
Respiratory tract 4 (4·0) 15 (16) 14 (25) 0·006 < 0·001 0·183
Abdomen 67 (67·0) 48 (51) 19 (33) 0·019 < 0·001 0·039
Urinary tract 0 (0) 4 (4) 6 (11) 0·038 0·001 0·128
Surgical site 12 (12·0) 16 (17) 13 (23) 0·335 0·075 0·365
Bacteraemia 0 (0) 6·30 (6) 12 (21) 0·011 < 0·001 0·006
Other 13 (13·0) 16 (17) 4 (7) 0·451 0·246 0·083
Microbiology
Positive culture 29 (29·0) 54 (57) 43 (75) < 0·001 < 0·001 0·021
Gram‐positive 13 (13·0) 29 (31) 21 (37) 0·003 < 0·001 0·422
Gram‐negative 23 (23·0) 31 (33) 34 (60) 0·133 < 0·001 0·001
Fungal 4 (4·0) 8 (8) 8 (14) 0·199 0·023 0·275
Measurements at diagnosis *
SOFA score 0 (0–1) 6 (3–8) 9 (7–11) < 0·001 < 0·001 < 0·001
Total bilirubin (mg/dl) 0·70 (0·4–1·03) 0·70 (0·43–1·78) 1·00 (0·56–1·89) 1·000 0·013 0·072
Glucose level (mg/dl) 118 (105–140) 158 (117·5–184) 163 (128–232·50) < 0·001 < 0·001 1·000
Sodium level (mmol/l) 139·00 (136–141·25) 138·00 (135–141·25) 129·00 (134–142) 0·008 < 0·001 0·001
Potassium level (mmol/l) 3·90 (3–4·10) 4·00 (3·50–4·20) 3·85 (3–4·12) § § §
Platelet count (cells/mm3) 221 500 (186 250–299 250) 184 000 (105 250–276 000) 123 000 (88 500–258 000) 0·023 0·001 0·794
INR 1·15 (1·03–1·26) 1·27 (1·16–1·35) 1·44 (1·27–1·81) 0·002 < 0·001 < 0·001
Albumin (mg/dl) 3480 (2737·5–4135) 2445 (2132·50–3130) 2340 (1837·5–2752·5) < 0·001 < 0·001 1·000
Lactate (mmol/l) 1·50 (1·06–1·85) 1·50 (1·23–2) 3·55 (2·46–5·19) 1·000 < 0·001 < 0·001
White blood cell count (cells/mm3) 13 070 (9187·5–16 347·5) 14 050 (9410–18 290) 14 550 (7525–19 880) § § §
Lymphocytes (cells/mm3) 1383·50 (911·50–1806·36) 940 (600·10–1453·86) 592 (410·08–1103·39) 0·021 < 0·001 0·004
Monocytes (cells/mm3) 795·52 (466·07–1099) 632 (345–962) 411·25 (245–791·56) 0·049 0·002 0·196
Neutrophils (cells/mm3) 10 144 (6327·70–13 864·48) 12 100 (7857–15 195) 12 240 (5647·50–18 177·50) 0·091 0·199 1·000
Eosinophils (cells/mm3) 43 (12·50–117·41) 19 (0–57·52) 10·92 (0–47·53) § § §
Basophils (cells/mm3) 33·60 (18–59·73) 26·90 (11·76–54·80) 20 (10·54–49·92) 0·827 0·042 0·196

Values in parentheses are percentages unless indicated otherwise;

*

values are median (i.q.r.). SOFA, Sequential Organ Failure Score; INR, international normalized ratio.

χ2 test, except

Kruskal–Wallis test;

§

absence of P value for χ2 or Kruskal–Wallis test, as appropriate.